Tributylmethylammonium

Tributylmethylammonium

SCHEMBL4020290

CCCC[N+](C)(CCCC)CCCC.CC[N+](C)(CC)C1CCCCC1.CS(=O)(=O)[O-].CS(=O)(=O)[O-]

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of Tributylmethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.31
ACHE P22303 1/20 0.31
BBOX1 O75936 2/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4641504 0.87 CA12 (0.32) BBOX1
SCHEMBL4441583 0.81 BBOX1 (0.43) BBOX1CYP1A2
SCHEMBL1028451 0.79 BBOX1 (0.41) BBOX1
Tributylmethylammonium SCHEMBL1618259 0.78 BBOX1 (0.40) BBOX1
Fluoride SCHEMBL29057134 0.78 BBOX1 (0.40) BBOX1
Sulfuric Acid SCHEMBL10988452 0.74 NAAA (0.36) BBOX1CYP1A2
SCHEMBL1030997 0.74 SHBG (0.35) CYP1A2
SCHEMBL27081613 0.74 SHBG (0.35) CYP1A2
SCHEMBL27505914 0.74 NAAA (0.40)
Sulfuric Acid SCHEMBL10912468 0.74 CYP1A2 (0.36) BBOX1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553406-B2 Process for removing polar impurities from hydrocarbons and mixtures of hydrocarbons MERCK PATENT GMBH (DE) 2009-06-30 US disclosed
US-20050010076-A1 Process for removing polar impurities from hydrocarbons and mixtures of hydrocarbons MERCK PATENT GMBH (DE) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010076-A1 Process for removing polar impurities from hydrocarbons and mixtures of hydrocarbons H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, HNRNPH3 BCHE 1083/4885ACHE 3700/4885BBOX1 2394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.